Viz.ai IPO

Viz.ai is a medical AI company that develops computer vision algorithms to help detect and triage critical conditions like strokes, pulmonary embolisms, and aneurysms in medical imaging. The company's AI platform analyzes CT scans in real-time and automatically alerts specialists when it detects signs of time-sensitive conditions, enabling faster treatment decisions.

The company has received FDA clearance for multiple AI applications and partners with major health systems across the United States. Viz.ai's platform has been credited with reducing time-to-treatment for stroke patients, which is critical since every minute of delay can result in significant brain damage. Their technology represents a significant advancement in emergency medical care, where rapid diagnosis can be the difference between life and death.